Products

Recombinant 2019-nCoV Guanine-N7_meth (N-6His)
EPT003
Size: Price:
50 μg $839.00

Overview

Product name: Recombinant 2019-nCoV Guanine-N7_meth (N-6His)
Description: Recombinant 2019-nCoV Guanine-N7 methyltransferase is produced by our E.coli expression system and the target gene encoding Ala1-Gln527 is expressed with a 6His tag at the N-terminus.
Accession: YP_009725309.1
Molecular weight: 62.9 KDa
Apparent molecular weight: 60 KDa, reducing conditions
Purity: Greater than 85% as determined by reducing SDS-PAGE.
Storage: Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.
Delivery condition: The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below.
Background: The nonstructural protein (nsp) 14 of SARS-CoV 2 was identified as a cap (guanine-N7)-methyltransferase (N7-MTase). Nsp14 of coronaviruses two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3' to 5' direction and a N7-guanine methyltransferase activity. It may be involved in the proof-reading ability during the viral RNA replication and transcription. GTP, dGTP as well as cap analogs GpppG, GpppA and m7GpppG could be methylated by nsp14.